LifeVantage News Inspires with Major International Announcements & New Luxury Skin Care Product
Featuring Dr. John C. Maxwell, Official 2017 Global Expansion Details & Launch of TrueScience® Hand Cream
SALT LAKE CITY – LifeVantage News “Elite Academy is one of my favorite events and Denver exceeded all expectations,” said Darren Jensen, LifeVantage President and Chief Executive Officer. “In addition to delivering valuable professional and personal development training, EA is an immensely powerful vehicle for helping the company succeed in our mission of biohacking the aging code and to activate the lives of millions of people.”
This was in reaction to LifeVantage Corporation (Nasdaq:LFVN), recently hosting an Elite Academy event for distributors, entrepreneurs, and business leaders in Denver, Colorado. The 3-day event presented vital corporate announcements, professional development seminar from top business experts and featured New York Times best-selling author, Dr. John C. Maxwell. LifeVantage has partnered with Dr. Maxwell to produce a modified leadership course based on his book, The 15 Invaluable Laws of Growth to help entrepreneurs learn the needed skills to succeed. The next LifeVantage seminar will be held at the company’s Elite Academy in Orlando, FL on November 2017.
LifeVantage news officially announced expansion plans for Germany and is currently preparing for a pre-launch tentatively scheduled on September 1, 2017. The pre-launch aims to provide customers a chance to buy products or enlist as distributors prior to the actual launch on January 20, 2018. Senior VP of International, Courtland Pearson said “Germany is one of the top five direct selling markets in the world. It will be a very important and strategic market for us with respect to the success of our global expansion efforts.”
The Company’s flagship product, Protandim® Nrf2 Synergizer, was also introduced to the Mexico market this week. “Protandim® Nrf2’s successful registration in Mexico is very exciting and we expect a strong response now that it’s officially available,” Mr. Jensen further stated.
LifeVantage news also introduced its newest luxury skincare product, TrueScience® Hand Cream. Highlighting premium naturally-produced ingredients and Nrf2 synergizers, supplies for the said product were immediately sold out. Information about TrueScience® and its availability can be found on LifeVantage’s website, www.lifevantage.com/truescience.
About LifeVantage Corporation
LifeVantage Corporation is a science-based health, wellness and anti-aging organization committed to helping people internally and externally transform themselves at a cellular level. Their scientifically-verified product line includes Protandim® Nrf2 and NRF1 Synergizers, TrueScience® Anti-Aging Skin Care Regimen, Petandim®, AXIO® Smart Energy and the PhysIQ™ Smart Weight Management System. LifeVantage (Nasdaq:LFVN) was established in 2003 and is hold office in Salt Lake City, Utah.
For more information, visit www.lifevantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as “believe,” “hopes,” “intends,” “estimates,” “expects,” “projects,” “plans,” “anticipates,” “look forward to” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding our future growth, distributor success and shareholder value. Such forward-looking statements are not guarantees of performance and the Company’s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company’s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company’s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, those discussed in greater detail in the Company’s Annual Report on Form 10-K and the Company’s Quarterly Report on Form 10-Q under the caption “Risk Factors,” and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.